Levamisole Impairs Vascular Function by Blocking α-Adrenergic Receptors and Reducing NO Bioavailability in Rabbit Renal Artery
-
Published:2024-06-14
Issue:8
Volume:24
Page:789-799
-
ISSN:1530-7905
-
Container-title:Cardiovascular Toxicology
-
language:en
-
Short-container-title:Cardiovasc Toxicol
Author:
Guerra-Ojeda Sol,Marchio Patricia,Suarez Andrea,Aldasoro Martin,Valles Soraya L.,Genoves Patricia,Vila Jose M.,Mauricio Maria D.
Abstract
AbstractLevamisole is an anthelmintic drug restricted to veterinary use but is currently detected as the most widely used cocaine cutting agent in European countries. Levamisole-adulterated cocaine has been linked to acute kidney injury, marked by a decrease in glomerular filtration rate, which involves reduced renal blood flow, but data on the alteration of renovascular response produced by levamisole are scarce. Renal arteries were isolated from healthy rabbits and used for isometric tension recording in organ baths and protein analysis. We provide evidence that depending on its concentration, levamisole modulates renovascular tone by acting as a non-selective α-adrenergic receptor blocker and down-regulates α1-adrenoceptor expression. Furthermore, levamisole impairs the endothelium-dependent relaxation induced by acetylcholine without modifying endothelial nitric oxide synthase (eNOS) expression. However, exposure to superoxide dismutase (SOD) partially prevents the impairment of ACh-induced relaxation by levamisole. This response is consistent with a down-regulation of SOD1 and an up-regulation of NADPH oxidase 4 (Nox4), suggesting that endothelial NO loss is due to increased local oxidative stress. Our findings demonstrate that levamisole can interfere with renal blood flow and the coordinated response to a vasodilator stimulus, which could worsen the deleterious consequences of cocaine use.
Graphical Abstract
EFS electric field stimulation, NA noradrenaline, AR adrenergic receptor, IP3 inositol 1, 4, 5-trisphosphate, cAMP cyclic adenosine monophosphate, mAChR muscarinic acetylcholine receptor, eNOS endothelial nitric oxide synthase, sGC soluble guanylyl cyclase, SOD superoxide dismutase, NOX4 NAPH oxidase 4
Funder
Ministerio de Universidades Universitat de Valencia
Publisher
Springer Science and Business Media LLC
Reference39 articles.
1. Khan, T. A., Cuchacovich, R., Espinoza, L. R., Lata, S., Patel, N. J., Garcia-Valladares, I., Salassi, M. M., & Sanders, C. V. (2011). Vasculopathy, hematological, and immune abnormalities associated with levamisole-contaminated cocaine use. Seminars in Arthritis and Rheumatism, 41, 445–454. https://doi.org/10.1016/j.semarthrit.2011.04.010 2. Dartevel, A., Chaigne, B., Moachon, L., Grenier, F., Dupin, N., Guillevin, L., Bouillet, L., & Mouthon, L. (2019). Levamisole-induced vasculopathy: A systematic review. Seminars in Arthritis and Rheumatism, 48, 921–926. https://doi.org/10.1016/j.semarthrit.2018.07.010 3. Larocque, A., & Hoffman, R. S. (2012). Levamisole in cocaine: Unexpected news from an old acquaintance. Clinical Toxicology, 50, 231–241. https://doi.org/10.3109/15563650.2012.665455 4. EMA EU/3/05/324. Retrieved March 6, 2023, from https://www.ema.europa.eu/en/medicines/human/orphan-designations/eu305324 5. EMA Elmisol: Withdrawn application. Retrieved March 6, 2023, from https://www.ema.europa.eu/en/medicines/human/withdrawn-applications/elmisol
|
|